Innovations Kapital
Signal active
Investment Firm
Overview
InnovationsKapital was founded in 1994 and is a leading independent venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in and Stockholm, Gothenburg and New York, is focused on investments within ICT and Healthcare & Life Sciences, dynamic sectors that are rapidly expanding and where Nordic research plays an important role.
The capital is provided by highly reputable Swedish and international institutional investors.
Highlights
Founded
1994
Industry
Financial Services
Employees
11-50
Investment
41
Lead Investment
10
Exits
15
Stages
Late Stage Venture, Early Stage Venture
Investor Type
Venture Capital
Location
Europe
Contact Information
Social
Profile Resume
Innovations Kapital, established in 1994 and headquartered in Europe., specializes in Late Stage Venture, Early Stage Venture investments across Software, Biotechnology, Health Care, Pharmaceutical, Venture Capital, Finance, CleanTech, Semiconductor, Manufacturing, Sensor. The organization boasts a portfolio of 41 investments, with an average round size of $8.9M and 15 successful exits. Their recent investments include Syntensia, Novavax, Sustainable Technologies Fund, Silecs, Tesi. The highest investment round they participated in was $14.2B. Among their most notable exits are Syntensia and Novavax. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Innovations Kapital has made 41 investments. Their most recent investment was on May 18, 2011, when Silecs raised $16.0M.
investments
41
Diversity investments
0
Lead investments
10
Number of exits
15
Investments
41
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jul 16, 2010 | Action Pharma | Biotechnology | 6.3M |
| Oct 18, 2010 | Oxeon | Manufacturing | null |
| May 13, 2011 | Paxport | Information Technology | null |
| May 18, 2011 | Silecs | Semiconductor | 16.0M |
Action Pharma
Paxport
SilecsExits
15
Funding Timeline
Funding rounds
41
Investors
0
Funds
0
Funding Rounds
41
Innovations Kapital has raised 41 rounds. Their latest funding was raised on May 18, 2011 from a Series E - Silecs round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jul 16, 2010 | Series C - Action Pharma | - | 6.3M | - |
| Oct 18, 2010 | Venture Round - Oxeon | - | 0 | - |
| May 13, 2011 | Venture Round - Paxport | - | 0 | - |
| May 18, 2011 | Series E - Silecs | - | 16.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.